There are five pathological types of nephrotic syndrome, and generally the efficacy of the microscopic lesion type is more satisfactory. The cure rate of this type of patients is about 70%, and 20%-30% are prone to relapse. Patients with focal segmental sclerosing nephritis and membranoproliferative nephritis are not treated well. The improvement rate of focal segmental sclerosing nephritis is 20%-40%, and the cure rate is still low, with a 60%-80% invalidity rate. The treatment effect of membranoproliferative nephritis is between the middle and severe stages of thylakoid proliferative nephritis, stages II, III and IV of membranous nephropathy, and a few focal segmental sclerosing nephritis, the efficacy is between the middle, some patients can show improvement, and some patients have a lower cure rate. Therefore, according to the traditional understanding, the cure rate of nephrotic syndrome is very low. At present, through the treatment for intractable proteinuria, the cure rate is very high by using the innovation of technology, and usually the cure rate can reach more than 80%-90%, and the improvement rate is also very satisfactory. However, the cure rate for patients with ineffective treatment of membranoproliferative nephritis is still low, but it is currently under research. Therefore, the cure rate of nephrotic syndrome varies for different pathological types. However, the cure rate has been improved by innovations in information technology.